Investigating how ceramide kinase helps manage cell death in damaged mitochondria
The role of ceramide kinase in mitophagy
This study is looking at a special enzyme called CERK that helps protect cells from dying when they get stressed out, especially in the mitochondria, which are like the powerhouses of the cell; by understanding how CERK works, we hope to find better ways to help people with conditions related to cell damage and inflammation.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10645030 on NIH RePORTER |
What this research studies
This research focuses on ceramide kinase (CERK) and its role in producing ceramide-1-phosphate (C1P), a molecule that may help protect cells from death during mitochondrial damage. The study examines how CERK is activated by cardiolipin and its location on the outer mitochondrial membrane. By manipulating CERK expression in cells, researchers aim to understand how this enzyme influences cell survival and death in response to mitochondrial stress. This could lead to insights into how to better manage conditions related to cell death and inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to mitochondrial dysfunction or cancer.
Not a fit: Patients with conditions unrelated to mitochondrial damage or those not experiencing cell death issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for protecting cells from death in various diseases, including cancer.
How similar studies have performed: Other research has shown promising results in understanding the role of ceramide and related pathways in cell survival, suggesting potential for success in this area.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Chalfant, Charles E. — University of Virginia
- Study coordinator: Chalfant, Charles E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.